OBJECTIVE -Risk scores based on phenotypic characteristics to identify individuals at high risk of having undiagnosed diabetes have been developed in Caucasian populations. The impact of known risk factors on having undiagnosed type 2 diabetes differs between populations from different ethnic origin, and risk scores developed in Caucasians may not be applicable to other ethnic groups. This study evaluated the performance of one risk score in nine populations of diverse ethnic origin.RESEARCH DESIGN AND METHODS -Data provided by centers from around the world to the DETECT-2 project were used. The database includes population-based surveys with information on at least 500 people without known diabetes having a 75-g oral glucose tolerance test. To date, 52 centers have contributed data on 190,000 individuals from 34 countries. In this analysis, nine cross-sectional studies were selected representing diverse ethnic and regional backgrounds. The risk score assessed uses information on age, sex, blood pressure treatment, and BMI.RESULTS -This analysis included 29,758 individuals; 1,805 individuals had undiagnosed diabetes. The performance of the risk score varied widely, with sensitivity, specificity, and percentage needing further testing ranging between 12 and 57%, 72 and 93%, and 2 and 25%, respectively, with the worse performance in non-Caucasian populations. This variation in performance was related to differences in the association between prevalence of undiagnosed diabetes and components of the risk score.CONCLUSIONS -A typical risk score developed in Caucasian populations cannot be applied to other populations of diverse ethnic origins.
Diabetes Care 29:410 -414, 2006T ype 2 diabetes is a common and serious condition associated with reduced life expectancy and considerable morbidity. Recent estimates suggest that currently 195 million people throughout the world have diabetes, and this will increase to over 330 million by 2025 (1). Approximately 50% of people with diabetes are undiagnosed (2,3). Because type 2 diabetes may remain undetected for several years, at the time of clinical diagnosis, many people have one or more micro-or macrovascular complications (4).Detecting people with undiagnosed type 2 diabetes is important for both public health policy and everyday clinical practice. Because of the rapidly increasing prevalence of type 2 diabetes (5-8), screening individuals at high risk of having undiagnosed diabetes is recommended in several countries (9 -11). Several questionnaires have been developed to detect this high-risk group (12-17). They all perform equally well, with a sensitivity of 70 -75% and a specificity of 55-70%. Because the majority of risk scores have been developed and validated in Caucasians (12,18), their applicability to populations of different ethnic background and with different risk factor distribution is uncertain.The DETECT-2 project is an international data pooling collaboration specifically addressing issues related to screening for type 2 diabetes, with an emphasis on the imp...